BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression
Open Access
- 1 September 2009
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 101 (7) , 1168-1174
Abstract
Background: Methods: Results: Conclusions:Keywords
This publication has 48 references indexed in Scilit:
- Interferon-Gamma Induces Prolyl Hydroxylase (PHD)3 Through a STAT1-Dependent Mechanism in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- The Complex Relationship between BRCA1 and ERα in Hereditary Breast CancerClinical Cancer Research, 2009
- The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapyBritish Journal of Cancer, 2009
- Targeting tumour hypoxia in breast cancerEuropean Journal of Cancer, 2008
- Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancerBreast Cancer Research, 2007
- Hypoxia-induced assembly of prolyl hydroxylase PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2Biochemical Journal, 2006
- Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markersBreast Cancer Research and Treatment, 2005
- Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast CarcinomaClinical Cancer Research, 2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002